Mark Day
Biochemistry
biOasis Technologies
Canada
Biography
Mark Day, Ph.D., is the president and chief executive officer at Bioasis Technologies, Inc. Dr. Day most recently served as head, CNS virtual discovery, at Purdue Pharma. Prior to joining Purdue Pharma, he served as executive director, head of external research and scouting, at Alexion Pharmaceuticals, Inc. Dr. Day also serves as adjunct associate professor at Yale University. He is widely recognized for his expertise and success in the recognition, evaluation and development of pipeline acquisition and collaboration targets across several therapeutic areas.
Research Interest
Biochemistry
